Cargando…
The FBW7-MCL-1 axis is key in M1 and M2 macrophage-related colon cancer cell progression: validating the immunotherapeutic value of targeting PI3Kγ
Colorectal cancer is a devastating disease with a low 5-year survival rate. Recently, many researchers have studied the mechanisms of tumor progression related to the tumor microenvironment. Here, we addressed the prognostic value of tumor-associated macrophages (TAMs) using a total of 232 CRC patie...
Autores principales: | Lee, Yeo Song, Song, Su Jeong, Hong, Hye Kyung, Oh, Bo Young, Lee, Woo Yong, Cho, Yong Beom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272616/ https://www.ncbi.nlm.nih.gov/pubmed/32444799 http://dx.doi.org/10.1038/s12276-020-0436-7 |
Ejemplares similares
-
SCF(Fbw7) Regulates Cellular Apoptosis By Targeting Mcl-1 for Ubiquitination and Destruction
por: Inuzuka, Hiroyuki, et al.
Publicado: (2011) -
Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7
por: Kim, Yeong Jun, et al.
Publicado: (2021) -
FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation
por: Tong, Jingshan, et al.
Publicado: (2016) -
Mcl‐1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer
por: Wang, Xu, et al.
Publicado: (2022) -
Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells
por: Lin, Lin, et al.
Publicado: (2020)